These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19936464)

  • 1. Late enhancement and myocardial perfusion in hypertrophic cardiomyopathy (comparison between groups).
    Barbosa CA; Castro CC; Avila LF; Parga Filho JR; Hattem DM; Fernandez EA
    Arq Bras Cardiol; 2009 Oct; 93(4):426-33, 418-25. PubMed ID: 19936464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of delayed enhancement in hypertrophic cardiomyopathy: relationship with left ventricular perfusion and contractile function.
    Soler R; Rodríguez E; Monserrat L; Méndez C; Martínez C
    J Comput Assist Tomogr; 2006; 30(3):412-20. PubMed ID: 16778615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
    Xu HY; Yang ZG; Sun JY; Wen LY; Zhang G; Zhang S; Guo YK
    Eur J Radiol; 2014 Apr; 83(4):665-72. PubMed ID: 24521610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
    Huang X; Yue Y; Wang Y; Deng Y; Liu L; Di Y; Sun S; Chen D; Fan L; Cao J
    Cardiovasc Ultrasound; 2018 Oct; 16(1):23. PubMed ID: 30285887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered autonomic cardiac control in hypertrophic cardiomyopathy. Role of outflow tract obstruction and myocardial hypertrophy.
    Limbruno U; Strata G; Zucchi R; Baglini R; Mengozzi G; Balbarini A; Mariani M
    Eur Heart J; 1998 Jan; 19(1):146-53. PubMed ID: 9503188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contractile Dysfunction in Sarcomeric Hypertrophic Cardiomyopathy.
    MacIver DH; Clark AL
    J Card Fail; 2016 Sep; 22(9):731-7. PubMed ID: 27090746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: first-pass myocardial perfusion cardiovascular magnetic resonance imaging at 1.5 T.
    Huang L; Han R; Ai T; Sun Z; Bai Y; Cao Z; Morelli JN; Xia L
    Clin Radiol; 2013 Jul; 68(7):676-82. PubMed ID: 23566329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between intraventricular myocardial systolic dyssynchrony and ventricular arrhythmias in patients with hypertrophic cardiomyopathy.
    D'Andrea A; Caso P; Severino S; Scotto di Uccio F; Vigorito F; Ascione L; Scherillo M; Calabrò R
    Echocardiography; 2005 Aug; 22(7):571-8. PubMed ID: 16060893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed enhancement magnetic resonance imaging in hypertrophic cardiomyopathy with Basal septal hypertrophy and preserved ejection fraction: relationship with ventricular tachyarrhythmia.
    Amano Y; Kitamura M; Tachi M; Takeda M; Mizuno K; Kumita S
    J Comput Assist Tomogr; 2014; 38(1):67-71. PubMed ID: 24378885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
    Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doppler tissue imaging: regional myocardial function in hypertrophic cardiomyopathy and in athlete's heart.
    Cardim N; Oliveira AG; Longo S; Ferreira T; Pereira A; Reis RP; Correia JM
    J Am Soc Echocardiogr; 2003 Mar; 16(3):223-32. PubMed ID: 12618730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients.
    Jablonowski R; Fernlund E; Aletras AH; Engblom H; Heiberg E; Liuba P; Arheden H; Carlsson M
    Pediatr Cardiol; 2015 Dec; 36(8):1662-9. PubMed ID: 26066352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dynamic obstruction and hypertrophy location on diastolic function in hypertrophic cardiomyopathy.
    Avegliano G; Costabel JP; Huguet M; Thierer J; Trivi M; Catalina TG; Petit M; Bijnens B; Frangi A; Ronderos R
    J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):207-13. PubMed ID: 24662413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of strain imaging in detecting segmental dysfunction in patients with hypertrophic cardiomyopathy.
    Yang H; Sun JP; Lever HM; Popovic ZB; Drinko JK; Greenberg NL; Shiota T; Thomas JD; Garcia MJ
    J Am Soc Echocardiogr; 2003 Mar; 16(3):233-9. PubMed ID: 12618731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.